Los Angeles, CA, Jan. 12, 2026 (GLOBE NEWSWIRE) — Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that protects the heart during pregnancy, shedding new light on the causes of peripartum cardiomyopathy (PPCM), a rare and life-threatening form of pregnancy-related heart failure. Read More
Source link
GA-Backed Acko Is Said to Hire Banks for $350 Million India IPO
(Bloomberg) — Acko Technology & Services Pvt., an Indian digital insurer backed by General Atlantic, has hired investment banks for a potential initial public offering that could raise as much…






